The powerful cardioprotective effects of urocortin and the corticotropin releasing hormone (CRH) family

被引:41
作者
Davidson, Sean M. [1 ,2 ]
Rybka, Aneta E. [3 ]
Townsend, Paul A. [3 ]
机构
[1] Univ Coll London Hosp, Hatter Cardiovasc Inst, London WC1E 6HX, England
[2] Sch Med, London WC1E 6HX, England
[3] Univ Southampton, Southampton Gen Hosp, Sch Med, Div Human Genet, Southampton SO16 6YD, Hants, England
基金
英国医学研究理事会; 英国生物技术与生命科学研究理事会;
关键词
Urocortin; Cardiovascular; Cardioprotection; Heart failure; Ischemia and reperfusion; MITOCHONDRIAL PERMEABILITY TRANSITION; ISCHEMIA-REPERFUSION INJURY; PROTEIN-KINASE-C; CARDIAC MYOCYTES; SKELETAL-MUSCLE; TUMOR-GROWTH; HUMAN HEART; EXPRESSION; PEPTIDES; PATHWAYS;
D O I
10.1016/j.bcp.2008.08.033
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The urocortins are members of the corticotropin releasing hormone (CRH) family of peptide hormones. The archetypal member of this family, CRH, plays an important role in regulating thermogenesis and homeostasis by acting centrally and systemically in target organs via its two receptors CRH-R1 and CRH-R2. However, by virtue of their much greater relative affinity for CRH-R2, the physiological effects of the urocortin peptides are largely restricted to peripheral organs such as the heart. A powerful cytoprotective effect of urocortin peptide administration against ischemia and reperfusion injury has been demonstrated in isolated cardiomyocyte models, as well as in the intact heart both in vitro and in vivo. Extremely promising data has shown the beneficial effect of treating pacing-induced heart failure in sheep with urocortin molecules. Though the efficacy and specificity of these molecules in humans is not yet established, molecular dissection of the cytoprotective pathways activated by urocortin peptides suggests that the beneficial effects may be separable from potentially deleterious effects. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:141 / 150
页数:10
相关论文
共 90 条
[1]   The mitochondrial permeability transition pore as a target of cardioprotective signaling [J].
Baines, Christopher P. .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2007, 293 (02) :H903-H904
[2]   The cardiovascular physiologic actions of urocortin II: Acute effects in murine heart failure [J].
Bale, TL ;
Hoshijima, M ;
Gu, Y ;
Dalton, N ;
Anderson, KR ;
Lee, KF ;
Rivier, J ;
Chien, KR ;
Vale, WW ;
Peterson, KL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (10) :3697-3702
[3]   Corticotropin-releasing factor receptor 2 is a tonic suppressor of vascularization [J].
Bale, TL ;
Giordano, FJ ;
Hickey, RP ;
Huang, Y ;
Nath, AK ;
Peterson, KL ;
Vale, WW ;
Lee, KF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (11) :7734-7739
[4]   Molecular regulation of cardiac hypertrophy [J].
Barry, Sean P. ;
Davidson, Sean M. ;
Townsend, Paul A. .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2008, 40 (10) :2023-2039
[5]   Urocortin protects against ischemic and reperfusion injury via a MAPK-dependent pathway [J].
Brar, BK ;
Jonassen, AK ;
Stephanou, A ;
Santilli, G ;
Railson, J ;
Knight, RA ;
Yellon, DM ;
Latchman, DS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (12) :8508-8514
[6]   Urocortin-II and Urocortin-III are cardioprotective against ischemia reperfusion injury: An essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart [J].
Brar, BK ;
Jonassen, AK ;
Egorina, EM ;
Chen, A ;
Negro, A ;
Perrin, MH ;
Mjos, OD ;
Latchman, DS ;
Lee, KF ;
Vale, W .
ENDOCRINOLOGY, 2004, 145 (01) :24-35
[7]   Urocortin increases the expression of heat shock protein 90 in rat cardiac myocytes in a MEK1/2-dependent manner [J].
Brar, BK ;
Railson, J ;
Stephanou, A ;
Knight, RA ;
Latchman, DS .
JOURNAL OF ENDOCRINOLOGY, 2002, 172 (02) :283-293
[8]   Activation of protein kinase B/Akt by urocortin is essential for its ability to protect cardiac cells against hypoxia/reoxygenation-induced cell death [J].
Brar, BK ;
Stephanou, A ;
Knight, R ;
Latchman, DS .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2002, 34 (04) :483-492
[9]   CRH-like peptides protect cardiac myocytes from lethal ischaemic injury [J].
Brar, BK ;
Stephanou, A ;
Okosi, A ;
Lawrence, KM ;
Knight, RA ;
Marber, MS ;
Latchman, DS .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1999, 158 (1-2) :55-63
[10]   Regulation of cell death protease caspase-9 by phosphorylation [J].
Cardone, MH ;
Roy, N ;
Stennicke, HR ;
Salvesen, GS ;
Franke, TF ;
Stanbridge, E ;
Frisch, S ;
Reed, JC .
SCIENCE, 1998, 282 (5392) :1318-1321